Board meeting on Oct 17, 2026 to approve Q2 FY27 results

Results View source PDF Explain this filing

ROSSARI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.0%Reaction day

₹409.00

prior close

₹409.80

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.8%+3.2% vs market

Specialty Chemicals peers, median of 102sector+0.4%+3.6% vs sector

On the reaction day the stock moved 3.2 pts more than Nifty Microcap 250 and 3.6 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.8

10m

+0.5

15m

+0.4

30m

-0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.0+0.8+3.2+0.4+3.6

Next day

+4.3+1.0+3.2+0.6+3.7

+5.6+1.7+3.9+1.6+4.1

+6.6+0.1+6.5+0.2+6.4

+11.2+0.8+10.5+0.9+10.3

+6.4-0.9+7.3-0.5+6.9

+4.9-4.5+9.4-4.7+9.6

15d

-0.7-4.8+4.1-6.1+5.3

—————

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 102Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Rossari Biotech has informed BSE that its Board of Directors will meet on October 17, 2026 to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026. The trading window for designated persons is already closed from October 1, 2026 until 48 hours after the results announcement, per the company's insider trading code.

Likely market impact

Routine compliance filing; no financial impact yet. Watch for actual Q2 FY27 numbers on Oct 17 for revenue and margin trends.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹697.6 Cr	₹586.1 Cr	+19.0%
Operating profit	₹48.20 Cr	₹47.60 Cr	+1.3%
Profit after tax	₹38.91 Cr	₹36.88 Cr	+5.5%
EBITDA margin	12.5%	12.3%	+0.2 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.